Travere Therapeutics (TVTX) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Travere Therapeutics (TVTX) over the last 14 years, with Q3 2025 value amounting to $89.5 million.
- Travere Therapeutics' Shares Outstanding rose 1482.19% to $89.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.5 million, marking a year-over-year increase of 1482.19%. This contributed to the annual value of $87.5 million for FY2024, which is 1603.58% up from last year.
- According to the latest figures from Q3 2025, Travere Therapeutics' Shares Outstanding is $89.5 million, which was up 1482.19% from $89.1 million recorded in Q2 2025.
- Travere Therapeutics' 5-year Shares Outstanding high stood at $89.5 million for Q3 2025, and its period low was $60.4 million during Q1 2021.
- For the 5-year period, Travere Therapeutics' Shares Outstanding averaged around $72.9 million, with its median value being $75.0 million (2023).
- As far as peak fluctuations go, Travere Therapeutics' Shares Outstanding skyrocketed by 4004.92% in 2021, and later skyrocketed by 198.04% in 2024.
- Over the past 5 years, Travere Therapeutics' Shares Outstanding (Quarter) stood at $62.5 million in 2021, then rose by 2.88% to $64.3 million in 2022, then rose by 17.23% to $75.4 million in 2023, then increased by 16.04% to $87.5 million in 2024, then grew by 2.29% to $89.5 million in 2025.
- Its Shares Outstanding was $89.5 million in Q3 2025, compared to $89.1 million in Q2 2025 and $88.8 million in Q1 2025.